Ridgewood Infrastructure Announced $1.2 Billion Final Close for Fund II, Significantly Surpassing Its Target

NEW YORK,Jan. 16,2025-- Ridgewood Infrastructure ("Ridgewood"),a leading investor in essential infrastructure in the U.S. lower middle market,today announced the final close of its second f

Tribal

Jan 16, 2025

Hurom Secures Victory in Korea Trade Commission Case Against NUC (Kuvings)

NUC Found Guilty of Patent Infringement,Ordered to Cease Activities,Pay Fines SEOUL,South Korea,Jan. 16,2025-- Hurom,the pioneer of low-speed masticating juicers and a global market leader,has succes

Tribal

Jan 16, 2025

CELEBRATING EXCELLENCE: 2025 AUSTRALIAN SMALL BUSINESS CHAMPION AWARDS

SYDNEY,Jan. 16,2025-- The stage is set for one of Australia\'s most prestigious celebrations of small business excellence!

Tribal

Jan 16, 2025

STRADVISION Introduces Data Management Workflow Model to Accelerate Mass Production of 'SVNet 3D Perception Network'

Enhancing 3D Data Processing Efficiency to Propel Next-Generation Algorithm Development of 3D Perception Network

Tribal

Jan 16, 2025

Ando Foundation and Nissin Food Products Release "Nourishing Wellbeing" Report: Second Study Again Proves Strong Relationship Between Food and Wellbeing

OSAKA,Japan,Jan. 14,2025-- The Ando Foundation (hereinafter "the Foundation") andNissin Food Products Co.,Ltd. (hereinafter "the Company"),in cooperation with Gallup,a global analy

Tribal

Jan 15, 2025

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch

Tribal

Jan 15, 2025

Tribal

Ridgewood Infrastructure Announced $1.2 Billion Final Close for Fund II, Significantly Surpassing Its Target

Hurom Secures Victory in Korea Trade Commission Case Against NUC (Kuvings)

CELEBRATING EXCELLENCE: 2025 AUSTRALIAN SMALL BUSINESS CHAMPION AWARDS

STRADVISION Introduces Data Management Workflow Model to Accelerate Mass Production of &#039;SVNet 3D Perception Network&#039;

Ando Foundation and Nissin Food Products Release &quot;Nourishing Wellbeing&quot; Report: Second Study Again Proves Strong Relationship Between Food and Wellbeing

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of &#039;Pemziviptadil&#039; for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

STRADVISION Introduces Data Management Workflow Model to Accelerate Mass Production of 'SVNet 3D Perception Network'

Ando Foundation and Nissin Food Products Release "Nourishing Wellbeing" Report: Second Study Again Proves Strong Relationship Between Food and Wellbeing

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS